Concepedia

Shengkai Zuo

SZ

Statistics

Publications

21

Citations

900

H-Index

16

Active since

2014

Affiliations

Tianjin Medical University(Current)

Shanghai Institutes for Biological Sciences

University of Chinese Academy of Sciences

Center for Excellence in Molecular Cell Science

Tsukuba International University

Shengkai Zuo is an author at Tianjin Medical University specializing in life sciences, cell signaling, and signal transduction.

Publications per year

2014–2025

21

Publications

21

EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2

Bei Wang, Yuxuan Jin, Jiao Liu et al. · Redox Biology · 2023 · 105 citations · Full text

Medicine, Cardiology, Pharmacology +15

PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation

Deping Kong, Yujun Shen, Guizhu Liu et al. · The Journal of Experimental Medicine · 2016 · 91 citations · Full text

Life Sciences, Cardiology, Immunology +17

CRTH2 promotes endoplasmic reticulum stress‐induced cardiomyocyte apoptosis through m‐calpain

Shengkai Zuo, Deping Kong, Chenyao Wang et al. · EMBO Molecular Medicine · 2018 · 81 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Inhibition of CRTH2-mediated Th2 activation attenuates pulmonary hypertension in mice

Guilin Chen, Shengkai Zuo, Juan Tang et al. · The Journal of Experimental Medicine · 2018 · 74 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice

Guizhu Liu, Qian Liu, Yujun Shen et al. · British Journal of Pharmacology · 2017 · 61 citations · Full text

Medicine, Cardiology, Pharmacology +14

1–5 of 21